welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy

key information

study id #: NCT03863119

condition: Duchenne Muscular Dystrophy

status: available


The intent of this protocol is to provide continued access to vamorolone for subjects in the United States who Have Completed the VBP15-LTE or VBP15- 004 protocols (and are thereby ineligible to enroll in another trial of vamorolone therapy), during the time a new drug application for vamorolone is under preparation and review.

intervention: Vamorolone

mechanism of action: Glucocorticoid to delay decline in muscle strength

results: https://clinicaltrials.gov/ct2/show/results/NCT03863119

last updated: December 23, 2019